Jane Leeder

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Zara Izadi, Erica J. Brenner, Satveer K. Mahil et al. · JAMA Network Open · 2021 · 116 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Low-dose infliximab treatment for ankylosing spondylitis--clinically- and cost-effective

Ramesh Jois, Jane Leeder, Alasdair J. Gibb et al. · Lara D. Veeken · 2006 · 62 citations

Medicine, Clinical Sciences, Pharmacotherapy +9

Influence of biologic therapy on return to work in people with work disability due to ankylosing spondylitis

Andrew Keat, Karl Gaffney, Annie K. Gilbert et al. · Lara D. Veeken · 2007 · 52 citations · Full text

Public Health, Clinical Sciences, Internal Medicine +17

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Sebastian E. Sattui, Richard Conway, Michael Putman et al. · The Lancet Rheumatology · 2021 · 51 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort

Fariz Yahya, Karl Gaffney, Louise Hamilton et al. · Lara D. Veeken · 2017 · 34 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13